145 related articles for article (PubMed ID: 17361333)
1. The combined effects of multiple chemotherapeutic agents for malignant glioma cells.
Nakagawa T; Kubota T; Ido K; Sakuma T; Matsuda K
J Neurooncol; 2007 Aug; 84(1):31-7. PubMed ID: 17361333
[TBL] [Abstract][Full Text] [Related]
2. Neuro-Oncology Working Group 01 trial of nimustine plus teniposide versus nimustine plus cytarabine chemotherapy in addition to involved-field radiotherapy in the first-line treatment of malignant glioma.
Weller M; Müller B; Koch R; Bamberg M; Krauseneck P;
J Clin Oncol; 2003 Sep; 21(17):3276-84. PubMed ID: 12947063
[TBL] [Abstract][Full Text] [Related]
3. [Synchronization chemoradiotherapy for malignant gliomas].
Yamamoto H; Sato F; Nakamura O; Kohno T; Shitara N; Takakura K; Sano K; Maehara T; Akanuma A
No Shinkei Geka; 1984 Jun; 12(7):795-805. PubMed ID: 6592471
[TBL] [Abstract][Full Text] [Related]
4. Down-regulation of O6-methylguanine-DNA methyltransferase gene expression in gliomas by platinum compounds.
Tanaka S; Kobayashi I; Utsuki S; Oka H; Yasui Y; Fujii K
Oncol Rep; 2005 Nov; 14(5):1275-80. PubMed ID: 16211296
[TBL] [Abstract][Full Text] [Related]
5. A phase II study of nimustine hydrochloride, cisplatin, and etoposide combination chemotherapy for supratentorial malignant gliomas.
Beppu T; Yoshida Y; Arai H; Wada T; Suzuki M; Ogawa A; Hakozaki S; Kubo N
J Neurooncol; 2000 Sep; 49(3):213-8. PubMed ID: 11212900
[TBL] [Abstract][Full Text] [Related]
6. Synergistic augmentation of antimicrotubule agent-induced cytotoxicity by a phosphoinositide 3-kinase inhibitor in human malignant glioma cells.
Shingu T; Yamada K; Hara N; Moritake K; Osago H; Terashima M; Uemura T; Yamasaki T; Tsuchiya M
Cancer Res; 2003 Jul; 63(14):4044-7. PubMed ID: 12874004
[TBL] [Abstract][Full Text] [Related]
7. Carboplatin and etoposide chemotherapy regimen for recurrent malignant glioma: a phase II study.
Jeremic B; Grujicic D; Jevremovic S; Stanisavljevic B; Milojevic L; Djuric L; Mijatovic L
J Clin Oncol; 1992 Jul; 10(7):1074-7. PubMed ID: 1318951
[TBL] [Abstract][Full Text] [Related]
8. Double-platinum chemotherapy combined with etoposide in metastatic brain tumor from small cell lung carcinoma.
Yamada SM; Yamada S; Takahashi H; Teramoto A; Nakayama H
J Neurooncol; 2005 Feb; 71(3):259-65. PubMed ID: 15735914
[TBL] [Abstract][Full Text] [Related]
9. [Evaluation of radiation immunochemotherapy in the treatment of malignant glioma. Combined use of ACNU, VCR and PS-K].
Kaneko S; Abe H; Aida T; Tokuda K; Tsuru M; Kitaoka K; Sato M; Iwakuma T; Ueno K; Kashiwaba T
Hokkaido Igaku Zasshi; 1983 Nov; 58(6):622-30. PubMed ID: 6584394
[TBL] [Abstract][Full Text] [Related]
10. Carboplatin combined with carmustine and etoposide in the treatment of glioblastoma.
Boiardi A; Silvani A; Milanesi I; Botturi M; Broggi G
Ital J Neurol Sci; 1992 Dec; 13(9):717-22. PubMed ID: 1483854
[TBL] [Abstract][Full Text] [Related]
11. Radiotherapy combined with nimustine hydrochloride and etoposide for malignant gliomas: results of a pilot study.
Tanaka M; Shibui S; Nomura K; Nakanishi Y
Jpn J Clin Oncol; 2001 Jun; 31(6):246-50. PubMed ID: 11463801
[TBL] [Abstract][Full Text] [Related]
12. [A clinical evaluation of combination therapy with radiation, MCNU, carboplatin and IFN-beta or with radiation, MCNU, carboplatin, etoposide and IFN-beta for malignant gliomas].
Mizumatsu S; Matsumoto K; Maeda Y; Tamiya T; Furuta T; Ohmoto T
Gan To Kagaku Ryoho; 1998 Nov; 25(13):2055-60. PubMed ID: 9838907
[TBL] [Abstract][Full Text] [Related]
13. [Role of thallium SPECT for evaluating the effect of maintenance chemotherapy against malignant gliomas].
Nagashima G; Fujimoto T; Suzuki R; Asai J; Chang CW
No Shinkei Geka; 2003 Dec; 31(12):1283-9. PubMed ID: 14719441
[TBL] [Abstract][Full Text] [Related]
14. [A case of recurrent malignant glioma treated by superselective intraarterial chemotherapy with a combination of etoposide and cisplatin].
Nakagawa H; Kubo S; Fujita T; Tsuruzono K; Miyawaki Y; Arita N; Hayakawa T
Gan To Kagaku Ryoho; 1992 Feb; 19(2):237-40. PubMed ID: 1736836
[TBL] [Abstract][Full Text] [Related]
15. PDCD5 promotes cisplatin-induced apoptosis of glioma cells via activating mitochondrial apoptotic pathway.
Li H; Zhang X; Song X; Zhu F; Wang Q; Guo C; Liu C; Shi Y; Ma C; Wang X; Zhang L
Cancer Biol Ther; 2012 Jul; 13(9):822-30. PubMed ID: 22688731
[TBL] [Abstract][Full Text] [Related]
16. Phase II study of nimustine, carboplatin, vincristine, and interferon-beta with radiotherapy for glioblastoma multiforme: experience of the Kyoto Neuro-Oncology Group.
Aoki T; Takahashi JA; Ueba T; Oya N; Hiraoka M; Matsui K; Fukui T; Nakashima Y; Ishikawa M; Hashimoto N
J Neurosurg; 2006 Sep; 105(3):385-91. PubMed ID: 16961130
[TBL] [Abstract][Full Text] [Related]
17. Intra-arterial mannitol infusion in the chemotherapy for malignant brain tumors.
Iwadate Y; Namba H; Saegusa T; Sueyoshi K
J Neurooncol; 1993 Feb; 15(2):185-93. PubMed ID: 8509823
[TBL] [Abstract][Full Text] [Related]
18. [Randomized comparative study of CE (CDDP plus etoposide) and CE-AVN (ACNU, VCR plus procarbazine) as combined anticancer chemotherapy in small cell cancer of the lung].
Kinoshita S; Bandou H; Yamashita T; Fukuta K; Yamasaki K; Matsuura A; Shimizu E; Ogura T; Doi H; Nakamura T
Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 1):643-8. PubMed ID: 2833178
[TBL] [Abstract][Full Text] [Related]
19. Preclinical evaluation of 9-chloro-2-methylellipticinium acetate alone and in combination with conventional anticancer drugs for the treatment of human brain tumor xenografts.
Arguello F; Alexander MA; Greene JF; Stinson SF; Jorden JL; Smith EM; Kalavar NT; Alvord WG; Klabansky RL; Sausville EA
J Cancer Res Clin Oncol; 1998 Jan; 124(1):19-26. PubMed ID: 9498830
[TBL] [Abstract][Full Text] [Related]
20. Differential responsiveness among "high risk" pediatric brain tumors in a pilot study of dose-intensive induction chemotherapy.
Jennings MT; Cmelak A; Johnson MD; Moots PL; Pais R; Shyr Y
Pediatr Blood Cancer; 2004 Jul; 43(1):46-54. PubMed ID: 15170889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
